Please find enclosed herewith the Scrutinizer''s Report of Postal Ballot alongwith Voting Results.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma Ltd has announced the results of a postal ballot conducted via remote e-voting from April 10, 2026 to May 9, 2026. Two special resolutions were passed with overwhelming shareholder approval. Resolution 1 approved the appointment of Mr. Vijayanarayanan Mahadevan as Non-Executive Independent Director for 5 years, receiving 99.72% votes in favour (5.18 crore votes out of 5.20 crore polled). Resolution 2 approved the appointment of Mr. Deepak Rameshchandra Shah as Non-Executive Independent Director for 5 years, also receiving 99.72% votes in favour. Total voter turnout was 49.14% of outstanding shares (5.20 crore votes out of 10.58 crore shares). Promoters voted unanimously in favour of both resolutions.
Both independent director appointments passed with strong shareholder backing, indicating confidence in the new board additions. The minimal opposition (less than 0.3%) from public shareholders suggests no governance concerns. This is a routine corporate governance update with neutral-to-positive implications for the stock.